Return to Article Details
IMPACT OF TYPE 2 DIABETES MELLITUS ON RIFAMPICIN PHARMACOKINETICS AND BIOCHEMICAL PATHWAYS IN PULMONARY TUBERCULOSIS PATIENTS
Download
Download PDF